Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
a long-chain acyl-CoA + NADPH + H+
a long-chain aldehyde + CoA + NADP+
-
-
-
-
?
a long-chain fatty acyl-CoA + NADPH + H+
a long-chain aldehyde + CoA + NADP+
AmFAR1 converts saturated fatty acids ranging from 16 to 22 carbon chains to their corresponding alcohols with the highest conversion efficiency shown on 18:0, AmFAR1 also shows some activities on ricinoleic acid, 16:1n-7 and 18:1n-9
aldehyde intermediate is immediately reduced to the corresponding alcohol
-
?
arachidonoyl-CoA + NADPH + H+
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenal + CoA + NADP+
Marinobacter nauticus
-
-
further reduction of (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenal into the corresponding (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraen-1-ol
-
?
arachidoyl-CoA + NADP+
eicosanal + CoA + NADPH
erucoyl-CoA + NADPH + H+
(13Z)-docos-13-enal + CoA + NADP+
Marinobacter nauticus
-
erucoyl-CoA i.e. (13Z)-docos-13-enoyl-CoA
further direct reduction of (13Z)-docos-13-enal into the corresponding (13Z)-docos-13-en-1-ol
-
?
fatty acyl-CoA + NADPH + H+
fatty aldehyde + CoA + NADP+
Marinobacter nauticus
-
-
reaction intermediate, enzyme converts fatty acyl-CoA directly into the corresponding fatty alcohol by four-electron reduction, free fatty aldehyde intermediate is not accessible
-
?
hexadecanoyl-CoA + NADPH + H+
hexadecanal + CoA + NADP+
-
-
-
-
?
icosanoyl-CoA + NADPH + H+
icosanal + CoA + NADP+
Marinobacter nauticus
-
-
further direct reduction of icosanal into the corresponding icosan-1-ol
-
?
lauroyl-CoA + NADP+
dodecanal + CoA + NADPH
lauroyl-CoA + NADPH + H+
dodecanal + CoA + NADP+
Marinobacter nauticus
-
-
further reduction of dodecanal into the corresponding dodecan-1-ol
-
?
myristoyl-CoA + NADP+
? + CoA + NADPH
myristoyl-CoA + NADPH
?
-
-
-
-
?
myristoyl-CoA + NADPH + H+
tetradecanal + CoA + NADP+
Marinobacter nauticus
-
-
further reduction of tetradecanal into the corresponding tetradecan-1-ol
-
?
octanoyl-CoA + NADPH + H+
octanal + NADP+
Marinobacter nauticus
-
-
further reduction of octanal into the corresponding octan-1-ol
-
?
oleoyl-CoA + NADPH + H+
(9Z)-octadec-9-enal + CoA + NADP+
palmitoleoyl-CoA + NADPH + H+
(9Z)-hexadec-9-enal + CoA + NADP+
Marinobacter nauticus
-
-
further reduction of (9Z)-hexadec-9-enal into the corresponding (9Z)-hexadec-9-en-1-ol
-
?
palmitoyl-ACP + NADPH
1-hexadecanol + acyl-carrier protein + NADP+
-
the recombinant acyl-CoA reductase from Simmondsia chinensis exhibits a specificty to palmitoyl-ACP and not palmitoyl-CoA when expressed in Escherichia coli
-
-
?
palmitoyl-CoA + NADP+
hexadecanal + CoA + NADPH
palmitoyl-CoA + NADPH + H+
hexadecanal + CoA + NADP+
palmitoyl-[acyl-carrier protein] + NADPH + H+
hexadecanal + [acyl-carrier protein] + NADP+
Marinobacter nauticus
-
-
further direct reduction of hexadecanal into the corresponding hexadecan-1-ol
-
?
ricinoleoyl-CoA + NADPH + H+
(9Z,12R)-12-hydroxyoctadec-9-enal + CoA + NADP+
Marinobacter nauticus
-
ricinoleoyl-CoA i.e. (9Z,12R)-12-hydroxyoctadec-9-enoyl-CoA
further direct reduction of (9Z,12R)-12-hydroxyoctadec-9-enal into the corresponding (9Z,12R)-octadec-9-ene-1,12-diol
-
?
stearoyl-CoA + NADP+
octadecanal + CoA + NADPH
44% of the activity with myristoyl-CoA
-
-
?
stearoyl-CoA + NADPH + H+
octadecanal + CoA + NADP+
tetradecanoyl-CoA + NADPH + H+
tetradecanal + CoA + NADP+
tetraeicos-cis-15-enoyl-CoA + NADPH
tetraeicos-cis-15-en-1-ol + CoA + NADP+
-
-
-
-
?
additional information
?
-
arachidoyl-CoA + NADP+

eicosanal + CoA + NADPH
29% of the activity with NADPH
-
-
?
arachidoyl-CoA + NADP+
eicosanal + CoA + NADPH
29% of the activity with NADPH
-
-
?
lauroyl-CoA + NADP+

dodecanal + CoA + NADPH
33% of the activity with myristoyl-CoA
-
-
?
lauroyl-CoA + NADP+
dodecanal + CoA + NADPH
33% of the activity with myristoyl-CoA
-
-
?
myristoyl-CoA + NADP+

? + CoA + NADPH
-
-
-
?
myristoyl-CoA + NADP+
? + CoA + NADPH
-
-
-
?
oleoyl-CoA + NADPH + H+

(9Z)-octadec-9-enal + CoA + NADP+
Marinobacter nauticus
-
-
further direct reduction of (9Z)-octadec-9-enal into the corresponding (9Z)-octadec-9-en-1-ol
-
?
oleoyl-CoA + NADPH + H+
(9Z)-octadec-9-enal + CoA + NADP+
Marinobacter nauticus
-
-
further reduction of (9Z)-octadec-9-enal into the corresponding (9Z)-octadec-9-en-1-ol
-
?
palmitoyl-CoA + NADP+

hexadecanal + CoA + NADPH
90% of the activity with myristoyl-CoA
-
-
?
palmitoyl-CoA + NADP+
hexadecanal + CoA + NADPH
90% of the activity with myristoyl-CoA
-
-
?
palmitoyl-CoA + NADPH + H+

hexadecanal + CoA + NADP+
-
-
-
-
r
palmitoyl-CoA + NADPH + H+
hexadecanal + CoA + NADP+
Marinobacter nauticus
-
-
further direct reduction of hexadecanal into the corresponding hexadecan-1-ol
-
?
palmitoyl-CoA + NADPH + H+
hexadecanal + CoA + NADP+
Marinobacter nauticus
-
-
further reduction of hexadecanal into the corresponding hexadecan-1-ol
-
?
stearoyl-CoA + NADPH + H+

octadecanal + CoA + NADP+
Marinobacter nauticus
-
-
further direct reduction of octadecanal into the corresponding octadecan-1-ol
-
?
stearoyl-CoA + NADPH + H+
octadecanal + CoA + NADP+
Marinobacter nauticus
-
-
further reduction of octadecanal into the corresponding octadecan-1-ol
-
?
tetradecanoyl-CoA + NADPH + H+

tetradecanal + CoA + NADP+
-
-
-
?
tetradecanoyl-CoA + NADPH + H+
tetradecanal + CoA + NADP+
-
-
-
-
?
tetradecanoyl-CoA + NADPH + H+
tetradecanal + CoA + NADP+
-
-
-
-
?
additional information

?
-
-
substrates with carbon chain lengths shorter thah 8 do not show any activity
-
-
?
additional information
?
-
substrates with carbon chain lengths shorter thah 8 do not show any activity
-
-
?
additional information
?
-
substrates with carbon chain lengths shorter thah 8 do not show any activity
-
-
?
additional information
?
-
no activity observed on 18:2n-6 and 18:3n-3
-
-
?
additional information
?
-
-
no activity observed on 18:2n-6 and 18:3n-3
-
-
?
additional information
?
-
catalyses the formation of a fatty alcohol from an acyl-CoA
-
-
?
additional information
?
-
catalyses the formation of a fatty alcohol from an acyl-CoA
-
-
?
additional information
?
-
catalyses the formation of a fatty alcohol from an acyl-CoA
-
-
?
additional information
?
-
catalyses the formation of a fatty alcohol from an acyl-CoA
-
-
?
additional information
?
-
catalyses the formation of a fatty alcohol from an acyl-CoA
-
-
?
additional information
?
-
-
enzyme only utilizes very long chain fatty acyl-CoAs as substrates, with activity on C26 > C24 > C22 > C20, but no activity on C18 and C16, enzyme is capable of using NADPH and NADH as electron donors, but prefers NADPH to NADH
-
-
?
additional information
?
-
Marinobacter nauticus
-
in contrast to other prokaryotes, the enzyme performs the two reduction steps from acyl-CoA to fatty alcohol in a single step which is typical for eukaryotes
-
-
?
additional information
?
-
Marinobacter nauticus
-
no reaction product detected with NADH or free fatty acids
-
-
?
additional information
?
-
Marinobacter nauticus
-
shorter acyl chains than 16 carbon are less effectively utilized and with these substrates substantial amounts of both free fatty acids and fatty aldehyde are formed
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Cataract
A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency.
Cataract
Fatty Acyl-CoA Reductase 1 Deficiency.
Epilepsy
A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency.
Epilepsy
Fatty Acyl-CoA Reductase 1 Deficiency.
Intellectual Disability
A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency.
Intellectual Disability
Fatty Acyl-CoA Reductase 1 Deficiency.
long-chain acyl-protein thioester reductase deficiency
A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency.
long-chain acyl-protein thioester reductase deficiency
A rare case of fatty acyl-CoA reductase 1 deficiency in an Indian infant manifesting rhizomelic chondrodystrophy phenotype.
long-chain acyl-protein thioester reductase deficiency
Familial Mitral Arcade, Tricuspid Dysplasia, Left Ventricular Noncompaction and Short-Chain Acyl-CoA Reductase Deficiency.
long-chain acyl-protein thioester reductase deficiency
Fatty Acyl-CoA Reductase 1 Deficiency.
Microcephaly
A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency.
Microcephaly
Fatty Acyl-CoA Reductase 1 Deficiency.
Neoplasms
Acyl-CoA reductase specificity and synthesis of wax esters in mouse preputial gland tumors.
Peroxisomal Disorders
A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency.
Tuberculosis
Catabolism of the Last Two Steroid Rings in Mycobacterium tuberculosis and Other Bacteria.
Zellweger Syndrome
Properties of the enzymes catalyzing the biosynthesis of lysophosphatidate and its ether analog in cultured fibroblasts from Zellweger syndrome patients and normal controls.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.